Ginkgo Bioworks DNA Remainder of Fiscal Year 2025
Remainder of Fiscal Year 2025 at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's remainder of fiscal year 2025.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ginkgo Bioworks's remainder of fiscal year 2025?
- Ginkgo Bioworks (DNA) reported remainder of fiscal year 2025 of $12.4M in Q1 2026.
- How has Ginkgo Bioworks's remainder of fiscal year 2025 changed year-over-year?
- Ginkgo Bioworks's remainder of fiscal year 2025 decreased by 12.9% year-over-year, from $14.24M to $12.4M.